Cargando…

Genetic modifiers of the BRD4-NUT dependency of NUT midline carcinoma uncovers a synergism between BETis and CDK4/6is

Bromodomain and extraterminal (BET) domain inhibitors (BETis) show efficacy on NUT midline carcinoma (NMC). However, not all NMC patients respond, and responders eventually develop resistance and relapse. Using CRISPR and ORF expression screens, we systematically examined the ability of cancer drive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Sida, Maertens, Ophélia, Cichowski, Karen, Elledge, Stephen J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory Press 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120715/ https://www.ncbi.nlm.nih.gov/pubmed/30135075 http://dx.doi.org/10.1101/gad.315648.118

Ejemplares similares

Deciphering the Role of microRNAs in BRD4-NUT Fusion Gene Induced NUT Midline Carcinoma
por: Pathak, Ekta, et al.
Publicado: (2017)

Supercharging BRD4 with NUT in carcinoma
por: Eagen, Kyle P., et al.
Publicado: (2021)

EZH2 synergizes with BRD4-NUT to drive NUT carcinoma growth through silencing of key tumor suppressor genes
por: Huang, Yeying, et al.
Publicado: (2023)

The BRD4–NUT Fusion Alone Drives Malignant Transformation of NUT Carcinoma
por: Durall, R. Taylor, et al.
Publicado: (2023)

A novel BRD4-NUT fusion in an undifferentiated sinonasal tumor highlights alternative splicing as a contributing oncogenic factor in NUT midline carcinoma
por: Stirnweiss, A, et al.
Publicado: (2015)

The Oncoprotein BRD4-NUT Generates Aberrant Histone Modification Patterns
por: Zee, Barry M., et al.
Publicado: (2016)

Structural mechanism of BRD4-NUT and p300 bipartite interaction in propagating aberrant gene transcription in chromatin in NUT carcinoma
por: Yu, Di, et al.
Publicado: (2023)

Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy
por: Engleson, Jens, et al.
Publicado: (2006)

Comparative drug screening in NUT midline carcinoma
por: Beesley, A H, et al.
Publicado: (2014)

NUT midline carcinoma of the head and neck: current perspectives
por: Napolitano, M, et al.
Publicado: (2019)

Clinicopathological and molecular characterizations of pulmonary NUT midline carcinoma
por: Xie, Mian, et al.
Publicado: (2021)

Usefulness of Nuclear Protein in Testis (NUT) Immunohistochemistry in the Cytodiagnosis of NUT Midline Carcinoma: A Brief Case Report
por: Park, Heae Surng, et al.
Publicado: (2014)

The first report of molecular characterized BRD4-NUT carcinoma in Brazil: a case report
por: Oliveira, Leandro J. C., et al.
Publicado: (2019)

Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitors
por: Riess, Jonathan W., et al.
Publicado: (2021)

Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma
por: Brägelmann, Johannes, et al.
Publicado: (2017)

SAT-125 A Tough NUT (Midline Carcinoma) to Crack
por: Lavelle, Kristen, et al.
Publicado: (2020)

Prolonged Survival of NUT Midline Carcinoma and Current Approaches to Treatment
por: Kaplan, Henry G, et al.
Publicado: (2023)

The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains
por: Alekseyenko, Artyom A., et al.
Publicado: (2015)

miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein
por: Tonouchi, Erina, et al.
Publicado: (2018)

Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma
por: Lee, J.-K., et al.
Publicado: (2017)

Alpha–fetoprotein elevation in NUT midline carcinoma: a case report
por: D’Ambrosio, Lorenzo, et al.
Publicado: (2017)

Case Report and Literature Review: Primary Pulmonary NUT-Midline Carcinoma
por: Zhang, Yunxiang, et al.
Publicado: (2021)

Molecular features driving condensate formation and gene expression by the BRD4-NUT fusion oncoprotein are overlapping but distinct
por: Kosno, Martyna, et al.
Publicado: (2023)

Molecular features driving condensate formation and gene expression by the BRD4-NUT fusion oncoprotein are overlapping but distinct
por: Kosno, Martyna, et al.
Publicado: (2023)

Should we go nuts about nuts?
por: Rohrmann, Sabine, et al.
Publicado: (2013)

Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline Carcinoma
por: Maur, Michela, et al.
Publicado: (2015)

NUT midline carcinoma in a young pregnant female: a case report
por: Joel, Sebastian, et al.
Publicado: (2020)

Clinical features, treatment, and survival outcome of primary pulmonary NUT midline carcinoma
por: Xie, Xiao-Hong, et al.
Publicado: (2020)

Successful treatment of a case with NUT midline carcinoma in the larynx and review of the literature
por: Zhang, Hai, et al.
Publicado: (2019)

Clinicopathological Analysis of Five Cases of NUT Midline Carcinoma, including One with the Gingiva
por: Zhou, Luting, et al.
Publicado: (2020)

NUT Midline Carcinoma: A Rare Solid Tumour Characterized by Chromosome Rearrangement
por: Zhang, Huan, et al.
Publicado: (2022)

Publisher Correction: miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein
por: Tonouchi, Erina, et al.
Publicado: (2018)

Cytological Features of a Variant NUT Midline Carcinoma of the Lung Harboring the NSD3-NUT Fusion Gene: A Case Report and Literature Review
por: Kuroda, Shiho, et al.
Publicado: (2015)

NUT midline carcinoma mimicking a germ cell tumor: a case report
por: Harada, Yohei, et al.
Publicado: (2016)

Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma
por: Zhang, Xin, et al.
Publicado: (2020)

Edible nuts /
por: Wickens, G. E.
Publicado: (1995)

Nuts and Cheese
Publicado: (1869)

The Betel Nut
Publicado: (1873)

Sinonasal NUT-Midline Carcinoma – A Multimodality Approach to Diagnosis, Staging and Post-Surgical Restaging
por: Shaikh, Faiq, et al.
Publicado: (2015)

How Much Can We Bet on Activity of BET Inhibitors Beyond NUT–Midline Carcinoma?
por: Martin-Romano, Patricia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uccv5otl9k4occgc2afq9b3thi